Famciclovir 250mg Tablet Franchise in Ahmedabad

Antiviral Tablet Supplier in Bangalore

Famciclovir Tablet Distributor in Hyderabad

Herpes & Shingles Tablet Franchise Opportunity in Jaipur

Viral Infection Tablet Stockist in Mumbai
Famciclovir Tablet Export & Manufacturing in Chandigarh

Home/Products /famciclovir-250mg-tablet

Famevile 250 Tablet

Composition : Famciclovir (250mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Famevile 250 Tablet contains Famciclovir 250mg, a potent antiviral medication widely used for the treatment of herpes simplex virus infections, shingles (herpes zoster), and other viral infections. It helps to reduce viral replication, shorten symptom duration, and prevent complications.

Famciclovir provides effective viral suppression with favorable tolerability, making it suitable for adults experiencing recurrent herpes outbreaks or acute viral infections requiring prompt intervention. Its oral formulation ensures convenient dosing and enhanced patient compliance.

For hospitals, clinics, and distributors, Famevile 250 Tablet is a high-demand antiviral, frequently prescribed by dermatologists, infectious disease specialists, and general practitioners. Its consistent clinical use ensures steady demand and repeat orders.

Adding Famevile 250 Tablet to your product portfolio strengthens your antiviral and infectious-disease segment, creating opportunities in hospital procurement, pharmacy distribution, export markets, institutional supply, and third-party manufacturing. Its clinical efficacy and widespread use make it a profitable and valuable product for pharmaceutical distributors.

Read More

About the Product

Famevile 250 Tablet contains Famciclovir 250mg, a potent antiviral medication widely used for the treatment of herpes simplex virus infections, shingles (herpes zoster), and other viral infections. It helps to reduce viral replication, shorten symptom duration, and prevent complications.

Famciclovir provides effective viral suppression with favorable tolerability, making it suitable for adults experiencing recurrent herpes outbreaks or acute viral infections requiring prompt intervention. Its oral formulation ensures convenient dosing and enhanced patient compliance.

For hospitals, clinics, and distributors, Famevile 250 Tablet is a high-demand antiviral, frequently prescribed by dermatologists, infectious disease specialists, and general practitioners. Its consistent clinical use ensures steady demand and repeat orders.

Adding Famevile 250 Tablet to your product portfolio strengthens your antiviral and infectious-disease segment, creating opportunities in hospital procurement, pharmacy distribution, export markets, institutional supply, and third-party manufacturing. Its clinical efficacy and widespread use make it a profitable and valuable product for pharmaceutical distributors.

Some patients may experience headache, nausea, diarrhea, or mild fatigue. Rarely, allergic reactions, dizziness, or liver enzyme elevation may occur.

Famevile 250 Tablet is indicated for the treatment of herpes zoster (shingles), genital herpes, and recurrent cold sores (herpes labialis). It helps reduce the severity, duration, and recurrence of symptoms caused by herpes virus infections.

Use strictly under medical supervision. Complete the full prescribed course to ensure effectiveness. Avoid in patients with known hypersensitivity to Famciclovir or related antivirals. Adjust dosage in patients with kidney impairment as advised by a physician.

Store in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation